gamma-aminobutyric acid has been researched along with Exanthem in 5 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To provide a qualitative, systematic update and review of the pharmacology, pharmacokinetics, efficacy in mood disorders, adverse effects, and costs of lamotrigine." | 8.81 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "Lamotrigine has positive effects on cognitive function, but occasionally produces insomnia." | 6.41 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| " A slow upward dose titration is recommended to reduce the incidence of serious rash, but this may delay the attainment of adequate dosage for 6 weeks." | 6.41 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "To provide a qualitative, systematic update and review of the pharmacology, pharmacokinetics, efficacy in mood disorders, adverse effects, and costs of lamotrigine." | 4.81 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "An 8-year-old boy with a neurodegenerative disease of unknown origin and an epilepsy disorder developed an urticarial rash and irritability 10 and 4 days, respectively, after the start of gabapentin 20 mg/kg 3 times a day for epilepsy control." | 3.75 | Probability of rash related to gabapentin therapy in a child. ( de Wildt, SN; Gijsen, VM; Ito, S, 2009) |
| "Lamotrigine has positive effects on cognitive function, but occasionally produces insomnia." | 2.41 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| " A slow upward dose titration is recommended to reduce the incidence of serious rash, but this may delay the attainment of adequate dosage for 6 weeks." | 2.41 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gijsen, VM | 1 |
| de Wildt, SN | 1 |
| Ito, S | 1 |
| Wang, XQ | 1 |
| Lang, SY | 1 |
| Shi, XB | 1 |
| Tian, HJ | 1 |
| Wang, RF | 1 |
| Yang, F | 1 |
| Wilton, LV | 1 |
| Shakir, S | 1 |
| Pellock, JM | 1 |
| Hurley, SC | 1 |
2 reviews available for gamma-aminobutyric acid and Exanthem
| Article | Year |
|---|---|
Overview of lamotrigine and the new antiepileptic drugs: the challenge.
Topics: Acetates; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Drug Interactions; Epilepsy; | 1997 |
Lamotrigine update and its use in mood disorders.
Topics: Acetates; Aggression; Amines; Antidepressive Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids; | 2002 |
3 other studies available for gamma-aminobutyric acid and Exanthem
| Article | Year |
|---|---|
Probability of rash related to gabapentin therapy in a child.
Topics: Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Epilepsy; Exanthema; Gabapentin; gamma- | 2009 |
Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Chi | 2010 |
A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England.
Topics: Acetates; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 an | 2002 |